S2 Ep98: What Cannabis Rescheduling Means for Pharmacists, Patients, and Psychiatric Care
In this episode of Psychiatric Pharmacy Pulse, host Megan Maroney, PharmD, BCPP, FAAPP, talks with Mary Bridgeman, PharmD, a pharmacist and clinical professor at the Ernest Mario School of Pharmacy at Rutgers, about the federal effort to move cannabis from Schedule I to Schedule III of the Controlled Substances Act. Bridgeman explains that the federal order covers FDA-approved cannabis products and those dispensed under state medical marijuana licenses. Adult-use cannabis, bulk plant material, and synthetically derived THC remain in Schedule I while the broader rescheduling goes through the…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.